DMAC
DiaMedica Therapeutics Inc.
$6.98
+$0.16(+2.35%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$360.27M
Volume
532.72K
52W Range
$3.19 - $7.49
Target Price
$12.33
EPS Estimates Overview
| Current Quarter | $-0.15 | Next Quarter | $-0.15 |
| Current Year | $-0.65 | Next Year | $-0.76 |
| QoQ Growth | +0.0% | YoY Growth | -16.9% |
| 3Y EPS CAGR | +2.6% | Target Price | $12.33 |
| Consensus | Buy | Upside | +76.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DMAC | $6.98 | +2.3% | 532.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get DiaMedica Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW